Fundraising FoxCape Fear BioCapital — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Eldec is a biotechnology company developing peptide-based therapeutics targeting SPLUNC1's modulation of Orai1 activity, with lead programs ELD615 and ELD607 for lung diseases such as cystic fibrosis and non-CF bronchiectasis.
BiotechHealthtechChapel Hill, US
Robert Tarran(Co-founder, President and Chief Scientific Officer)inSaira Ahmad(Co-founder; Director of Science)inFlori Sassano(Co-founder; Director, Research Operations)Robert J. Schotzinger(Chairman and Chief Executive Officer)Robert Hughes(Chief Financial Officer)Dale J. Christensen(Chief Development Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.